HealthQuill Articles by: HealthQuill
The USFDA has approved two treatments for sickle cell disease, one of them the first in the US based on gene-editing technology.
Drugs Health Pharma

US drug regulator approves two treatments for sickle cell diseaseĀ 

HQ Team December 8, 2023: The USFDA has approved two treatments for sickle cell disease, one of them the first in the US

Read More
The current global risk from cholera is ā€œvery highā€ with vaccines running short of demand, the World Health Organization stated.
Drugs Health Pharma

WHO maintains global cholera risk at ā€œvery highā€ category

HQ Team December 8, 2023: The current global risk from cholera is ā€œvery highā€ with vaccines running short of demand, the World Health

Read More
A record number of 2,456 fuel lobbyists, tied to the worldā€™s biggest polluting oil and gas firms and their trade groups, have been granted access to the COP28 summit in Dubai.
Climate Health Pharma

Fuel lobbyists swarm COP28, creating a ā€˜fog of climate denialā€™

HQ Team December 8, 2023: A record number of 2,456 fuel lobbyists, tied to the worldā€™s biggest polluting oil and gas firms and

Read More
Global nations have raised $83.3 billion so far for financing climate change, according to COP28, the UN Climate Change Conference.
Climate Health Pharma

UN’s COP28 raises $83.3 billion to finance climate change

HQ Team December 7, 2023: Global nations have raised $83.3 billion so far for financing climate change, according to COP28, the UN Climate

Read More
AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to boost the North Chicago, Illinois-based companyā€™s presence in the psychiatric and neurological disorder segment.
Drugs Health Pharma

AbbVie to acquire Cerevel for $8.7b to bolster neurological treatments

HQ Team December 7, 2023: AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to

Read More
About 40 million women, or one-third, were likely to have a long-term childbirth-related health problem, which is often ignored in clinical research, practice and policy, a Lancet report quoted by the WHO stated.
Health Medical Pharma

40 million women susceptible to long-term childbirth health issues: Study

HQ Team December 7, 2023: About 40 million women, or one-third, were likely to have a long-term childbirth-related health problem, which is often

Read More
Climate funds sanctioned by nations globally for Indigenous Peoples and local communities tend to ā€œevaporateā€ when channelled through third parties, according to a report.
Climate Health Pharma

Funds allotted to indigenous people, local communities ‘evaporate’: GATC

HQ Team December 7, 2023: Climate funds sanctioned by nations globally for Indigenous Peoples and local communities tend to ā€œevaporateā€ when channelled through

Read More
The ongoing annual UN climate conference in Dubai, COP28, must deliver a bullet train to speed up climate action and stop the current ā€œold caboose chugging over rickety tracks,ā€ UN Climate Chief, Simon Stiell said.
Climate Health Pharma

Get off rickety tracks, deliver a ā€˜bullet trainā€™ on climate action: UN

HQ Team December 6, 2023: The ongoing annual UN climate conference in Dubai, COP28, must deliver a bullet train to speed up climate

Read More
lyme disease
Health Medical Pharma

Pfizer and Valneva announce relaunch of Lyme disease vaccine trial

HQ Team December 6, 2023: Pfizer and Valneva SE announced that they have finalized enrolment in the VALOR Phase III trial of their

Read More
Junior hospital doctors, who make up about half of the National Health Service (NHS) medical workforce in England, are going on the longest strike in NHS history around Christmas and January after pay talks with the government failed.
Drugs Health Pharma

UK’s junior NHS doctors to strike around Christmas, pay talks failĀ 

HQ Team December 6, 2023: Junior hospital doctors, who make up about half of the National Health Service (NHS) medical workforce in England,

Read More